These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30562647)

  • 1. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.
    Almohmeed YH; Avenell A; Aucott L; Vickers MA
    PLoS One; 2013; 8(4):e61110. PubMed ID: 23585874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
    Castellazzi M; Delbue S; Elia F; Gastaldi M; Franciotta D; Rizzo R; Bellini T; Bergamaschi R; Granieri E; Fainardi E
    Dis Markers; 2015; 2015():901312. PubMed ID: 26101453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J; Tengvall K; Lima IB; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
    Brain; 2024 Oct; 147(10):3573-3582. PubMed ID: 38630618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
    Neurology; 2004 Jun; 62(12):2277-82. PubMed ID: 15210894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
    Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
    Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus reactivation and multiple sclerosis.
    Torkildsen Ø; Nyland H; Myrmel H; Myhr KM
    Eur J Neurol; 2008 Jan; 15(1):106-8. PubMed ID: 18042233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.